Home > ResourceBlog > Article

« All ResourceBlog Articles

 

Bookmark and Share   Feed

Saturday, 30th October 2010

Scholarly Publishing: "Conflicts of Interest at Medical Journals: The Influence of Industry-Supported Randomised Trials on Journal Impact Factors and Revenue – Cohort Study"

From the Abstract of a New PLOS Medicine Article:

Transparency in reporting of conflict of interest is an increasingly important aspect of publication in medical journals. Publication of large industry-supported trials may generate many citations and journal income through reprint sales and thereby be a source of conflicts of interest for journals. We investigated industry-supported trials' influence on journal impact factors and revenue.

Methods and Findings

We sampled six major medical journals (Annals of Internal Medicine, Archives of Internal Medicine, BMJ, JAMA, The Lancet, and New England Journal of Medicine [NEJM]). For each journal, we identified randomised trials published in 1996–1997 and 2005–2006 using PubMed, and categorized the type of financial support. Using Web of Science, we investigated citations of industry-supported trials and the influence on journal impact factors over a ten-year period. We contacted journal editors and retrieved tax information on income from industry sources. The proportion of trials with sole industry support varied between journals, from 7% in BMJ to 32% in NEJM in 2005–2006. Industry-supported trials were more frequently cited than trials with other types of support, and omitting them from the impact factor calculation decreased journal impact factors. The decrease varied considerably between journals, with 1% for BMJ to 15% for NEJM in 2007. For the two journals disclosing data, income from the sales of reprints contributed to 3% and 41% of the total income for BMJ and The Lancet in 2005–2006.

Conclusions

Publication of industry-supported trials was associated with an increase in journal impact factors. Sales of reprints may provide a substantial income. We suggest that journals disclose financial information in the same way that they require them from their authors, so that readers can assess the potential effect of different types of papers on journals' revenue and impact.

Access the Full Text of Article

See Also: Perspective: "Editors, Publishers, Impact Factors, and Reprint Income"
by Harvey Marcovitch

Editors would like to imagine they are simply gatekeepers who facilitate the interaction between authors who wish to impart information and people who want to read it. In fact, they are subject to a raft of external pressures that interfere with this core task. Coauthors are prone to disputes with each other and with reviewers; rejected authors may protest; readers may be dissatisfied; institutions may react inadequately to editors' concerns about probity; editorial freedom may be compromised by the demands of the learned society that owns the journal; and a commercial publisher might exert subtle—or unsubtle—pressure to increase profitability. All of these distractions increase the possibility of competing interests corrupting the editorial process.

Influence of the Impact Factor Top

Added to this toxic mixture is the impact factor (IF). Just as many clinicians claim that contacts by pharmaceutical company representatives do not affect their prescribing behaviour, so editors are likely to deny that thoughts of a rising IF might influence their acceptance rates. In their paper published this week in PLoS Medicine, Andreas Lundh and colleagues analysed randomised controlled trials published in six high-impact general medical journals during two time periods a decade apart; they calculated the putative fall in IF that would have occurred had publication been denied to papers that were commercially sponsored.

Source: PLOS Medicine


Category:

Views: 2979




« All ResourceBlog Articles

 

FreePint

FreePint supports the value of information in the enterprise. Read more »


FeedLatest FreePint Content:


  • Click to view the article Product Review of Factiva Companies & Executives (Introduction; Contact Details)
    Tuesday, 16th September 2014

    Chris Porter looks at the Companies & Executives component of the Dow Jones Factiva service. This component contains data and tools relating to companies, executives and industries. It was previously sold separately, but is now fully integrated into the main Factiva product. Factiva Companies & Executives is aimed at researchers and analysts in information-intensive organisations, as well as those involved in sales and business development. In the first part of the review Chris introduces the product and company and provides contact details.

  • Click to view the article Are Companies Making the Most of SharePoint?
    Tuesday, 16th September 2014

    SharePoint is much more than just a document collaboration tool; its social and collaborative elements are continually being strengthened and it now also serves as a social computing platform. But how many companies are actually taking advantage of all of its features? This is a question that often remains unanswered, so it was with some interest that I read an article which looks at research into the ways companies are really using SharePoint.

  • Click to view the article Key Differentiators - Pay As You Go Market Research Providers
    Monday, 15th September 2014

    If you're looking for company, industry or country information on a Pay As You Go basis, the wealth of online market research sources can seem quite overwhelming. In her article, Sophie Alexander highlights the key differentiators of four well-known market research vendors, including the type of content, publishers, search features, account options as well as geographical and language coverage.

  • ... more ...

All FreePint Content »
FreePint Topics »


A FreePint Subscription delivers articles and reports that support your organisation's information practice, content and strategy.

Find out more and order a FreePint Subscription by visiting the
completing our online form: Subscription Order page.


FreePint Testimonials

"As a service providing practical support and guidance for what professionals do FreePint is pretty unique and decent value for money." ..."

Read more testimonials and supply yours »






 

 
 
 

Register

Register to receive the free ResourceShelf Newsletter, featuring highlighted posts.

Find out more »

Article Categories

All Article Categories »

Archive

All Archives »